Complete Guide to NIPS (Non-Invasive Prenatal Screening)

What Is NIPS/NIPT?

Non-invasive prenatal screening (NIPS), also called the non-invasive prenatal test (NIPT), is an advanced blood test performed during pregnancy to assess your baby's risk for specific chromosomal conditions. The NIPS test analyses tiny DNA fragments from your placenta that naturally circulate in your bloodstream, providing valuable genetic information about your developing baby.

NIPS primarily screens for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome)—the three most common chromosomal conditions affecting live births. The test examines cell-free DNA in your blood, which includes genetic material from the placenta that typically reflects your baby's chromosomes. Unlike invasive procedures, the NIPS blood test poses no miscarriage risk, making it an attractive option for expectant parents.

The NIPS test during pregnancy can be performed as early as 10 weeks of gestation, offering early reassurance or enabling timely decision-making. Many healthcare providers now offer this NIPS screening test to all pregnant women after appropriate counselling, recognising its value in modern prenatal care.

How NIPS Works: The Science Behind cfDNA & Placental DNA

The NIPS test during pregnancy looks for tiny cfDNA (cell-free DNA) fragments in the mother’s blood to check for chromosomal conditions in the baby. These DNA pieces come mostly from the placenta, which releases small fragments of foetal DNA into the mother’s bloodstream. By the second trimester, around 10–20% of the total cell-free DNA in maternal blood originates from the placenta.

As per a study published in PubMed Central, foetal DNA from the placenta mixes with the mother’s DNA. Using next-generation sequencing (NGS), the test measures how much DNA comes from each chromosome. By the second trimester, around 10–20% of the total cell-free DNA in maternal blood originates from the placenta. Foetal DNA fragments are usually slightly shorter, which helps labs tell them apart from maternal DNA.

Sequencing technology compares the amount and pattern of DNA to look for extra or missing chromosomal material. It also examines specific genetic markers to improve accuracy.

Why NIPS Is Considered a Non-Invasive Test

NIPS is considered ‘non-invasive’ because it requires only a standard maternal blood draw, avoiding any risk associated with uterine or foetal sampling. Unlike invasive diagnostic procedures such as amniocentesis or chorionic villus sampling, the NIPS blood test doesn't involve entering your uterus or directly sampling foetal tissue.

This approach eliminates procedure-related risks, including miscarriage complications associated with invasive testing. The NIPS screening test poses no direct physical risk to your baby and carries no additional pregnancy loss risk beyond routine blood collection. This safety profile makes the NIPS test particularly appealing for early pregnancy screening.

When Can You Get NIPS Done? Timing and Gestational Age

• Optimal timing: The NIPS test during pregnancy typically begins at 10 weeks of gestation.
• Early options: Some laboratories may perform testing from 9 weeks onward, but success depends on achieving a sufficient foetal fraction (usually ≥4%).
• Timing rationale: Earlier testing often fails due to insufficient placental DNA in maternal blood.
• Multiple pregnancies: NIPS performs best in singleton pregnancies; in twins, accuracy is lower and interpretation more complex.
• Scheduling considerations: Often performed instead of or alongside first-trimester screening, before considering diagnostic tests.
• Repeat testing: Failed NIPS test results due to low foetal fraction may prompt later retesting or diagnostic evaluation.

What Conditions Does NIPS Screen For?

The NIPS screening test detects core chromosomal conditions with strong validation:

• Down syndrome (Trisomy 21): The most common chromosomal cause of intellectual disability screened by the NIPS test.
• Edwards syndrome (Trisomy 18): Often associated with severe developmental delays and structural abnormalities.
• Patau syndrome (Trisomy 13): Linked to severe brain, heart, and other organ abnormalities.

The NIPT test also detects sex chromosome conditions (panel-dependent):

• Turner syndrome (Monosomy X): A female condition affecting growth and development.
• Klinefelter syndrome (XXY): A male condition potentially affecting fertility and development.
• Additional sex chromosome variations: Including XYY and XXX conditions.

Expanded NIPS screening options include:

• Microdeletion syndromes: Some expanded NIPS panels include small chromosomal deletions (like 22q11.2), but clinical validation remains limited.
• Foetal sex determination: Highly accurate when requested as part of routine screening.

What NIPS Can't Detect: Limitations of the Test

• Diagnostic limitations: NIPS test results provide risk estimates, not definitive diagnoses requiring confirmation through invasive testing.
• Genetic coverage gaps: Cannot detect most single-gene disorders or structural chromosomal rearrangements.
• Structural birth defects: The NIPS screening test doesn't replace detailed ultrasound examinations for physical abnormalities.
• Placental mosaicism: Discrepancies between placental and foetal genetics can cause false-positive or false-negative NIPS test results.
• Multiple pregnancy complications: Vanishing twin syndrome or undiagnosed multiples can affect NIPS test accuracy.
• Technical limitations: Low foetal fraction due to maternal weight, medications, or placental issues can compromise results.

Accuracy of NIPS: Sensitivity, Specificity, and Detection Rates

NIPS demonstrates very high accuracy for major chromosomal conditions, although confirmatory testing is still required for diagnostic certainty. For Down syndrome, NIPS genetic testing achieves detection rates exceeding 99%, with false-positive rates below 0.1%. Edwards syndrome and Patau syndrome show similarly high detection rates, though slightly lower than Down syndrome screening.

• Down syndrome detection: Greater than 99% sensitivity with a 0.01-0.05% false-positive rate.
• Edwards syndrome accuracy: Approximately 98% detection rate with a 0.01-0.03% false-positive rate.
• Turner syndrome performance: Around 95% detection rate, though more variable than autosomal trisomies.

These accuracy levels explain why NIPS has become a preferred first-line prenatal screening method worldwide, offering superior accuracy compared to traditional biochemical screening methods while maintaining the safety of non-invasive testing.

Who Should Consider NIPS?

• All pregnant women: Current ACOG and FOGSI guidelines support offering NIPS to all expectant mothers following appropriate pre-test counselling.
• Advanced maternal age: Women 35 and older face increased chromosomal abnormality risks.
• Previous affected pregnancies: History of chromosomal conditions in prior pregnancies.
• Abnormal screening results: Follow-up for concerning biochemical or ultrasound findings.
• Family history concerns: Genetic counselling may recommend the NIPS screening test for hereditary risk factors.
• Patient preference: Desire for early, safe screening without invasive procedure risks.

NIPS vs. Other Prenatal Screening Tests

What Do NIPS Results Mean?

Understanding your NIPS test results requires recognising that this screening provides risk estimates rather than definitive answers. The test categorises results as low risk, high risk, or inconclusive based on statistical analysis of chromosomal DNA patterns.

1. Low-risk results: Indicate reduced probability of screened conditions, though a small residual risk remains.
2. High-risk results: Suggest increased likelihood requiring confirmatory diagnostic testing through amniocentesis or CVS.
3. Inconclusive results: Occur when foetal fraction is insufficient or technical issues arise, often prompting repeat testing.

Next Steps After NIPS Results: Genetic Counselling & Diagnostic Testing

Regardless of your NIPS test results, genetic counselling is essential for interpreting NIPS results, understanding next steps, and making informed pregnancy decisions. High-risk results don't confirm chromosomal conditions but indicate the need for diagnostic testing. Genetic counsellors help interpret NIPS test accuracy limitations and discuss options, including amniocentesis or chorionic villus sampling for definitive diagnosis.

Possible Outcomes of NIPS: Low Risk, High Risk, and Inconclusive

1. Low-risk outcome: Reassurance that screened conditions are unlikely, allowing continued routine prenatal care.
2. High-risk outcome: Requires genetic counselling and consideration of diagnostic testing for confirmation.
3. Inconclusive outcome: May necessitate repeat NIPS testing, alternative screening methods, or direct diagnostic evaluation.

Ethical Considerations in NIPS

The widespread availability of the NIPS test raises important ethical questions about pregnancy management and societal attitudes towards genetic conditions. While the test provides valuable information, decisions about continuing or terminating pregnancies remain deeply personal choices requiring careful consideration of family values, support systems, and medical guidance.

Practical Considerations for Expectant Parents in India

• NIPT test price: At Metropolis Healthcare, the NextGen NIPT (Non-Invasive Prenatal Screening) costs ₹16,000, while the NextGen NIPT Advance (Non-Invasive Prenatal Screening Advance) is priced at ₹20,000.
• Insurance coverage: Check with your insurance provider to confirm whether NIPS genetic testing is covered under your policy.
• Laboratory selection: Choose accredited centres with a strong track record for NIPS accuracy. Metropolis Healthcare offers easy access through its NABL & CAP accredited laboratories.
• Timing coordination: Schedule NIPS alongside your routine prenatal appointments for smoother care planning.
• Support systems: Seek support from family and qualified genetic counsellors before proceeding, especially if testing may influence major decisions.
• Follow-up planning: Be aware of the recommended next steps for all possible NIPS results.

Conclusion

Understanding how NIPS works empowers you to make informed, confident prenatal care decisions with your healthcare team. This safe, accurate screening tool provides valuable insights into your baby's chromosomal health, supporting your journey towards parenthood with greater confidence and knowledge.

At Metropolis Healthcare, we understand the importance of accurate, reliable prenatal screening during this precious time. Our comprehensive portfolio of over 4,000 advanced tests includes state-of-the-art NIPS genetic testing, delivered through our extensive network of 220+ laboratories and 10,000+ touchpoints across India. With convenient home sample collection, rapid turnaround times, and clinically validated accuracy, Metropolis supports your family’s prenatal journey with expertise and compassion.